{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:02:11Z","timestamp":1774616531343,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["GCU-202310060001"],"award-info":[{"award-number":["GCU-202310060001"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04259-w","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:54:50Z","timestamp":1771548890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perineural invasion as an independent predictor of early recurrence within 1 year after total mesorectal excision for rectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Youngbae","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Jin","family":"Sym","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Heum","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"4259_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4259_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000120628","volume":"73","author":"M Li","year":"2007","unstructured":"Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology. 2007;73:52\u20137. https:\/\/doi.org\/10.1159\/000120628.","journal-title":"Oncology"},{"key":"4259_CR3","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1002\/onco.13815","volume":"26","author":"LC Chang","year":"2021","unstructured":"Chang LC, Shun CT, Lin BR, Sanduleanu S, Hsu WF, Wu MS, et al. Recurrence outcomes less favorable in T1 rectal cancer than in T1 colon cancer. Oncologist. 2021;26:e1548\u201354. https:\/\/doi.org\/10.1002\/onco.13815.","journal-title":"Oncologist"},{"key":"4259_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54943-8","volume":"14","author":"S Alinia","year":"2024","unstructured":"Alinia S, Ahmadi S, Mohammadi Z, Rastkar Shirvandeh F, Asghari-Jafarabadi M, Mahmoudi L, et al. Exploring the impact of stage and tumor site on colorectal cancer survival: Bayesian survival modeling. Sci Rep. 2024;14:4270. https:\/\/doi.org\/10.1038\/s41598-024-54943-8.","journal-title":"Sci Rep"},{"key":"4259_CR5","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1200\/JCO.22.02166","volume":"41","author":"R Ruppert","year":"2023","unstructured":"Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, et al. Risk-adapted neoadjuvant chemoradiotherapy in rectal cancer: final report of the OCUM study. J Clin Oncol. 2023;41:4025\u201334. https:\/\/doi.org\/10.1200\/JCO.22.02166.","journal-title":"J Clin Oncol"},{"key":"4259_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3857\/roj.2023.01032","volume":"42","author":"JH Lee","year":"2024","unstructured":"Lee JH, Kim N, Yu JI, Yoo GS, Park HC, Lee WY, et al. Clinical outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision in locally advanced rectal cancer with mesorectal fascia involvement. Radiat Oncol J. 2024;42:130\u20138. https:\/\/doi.org\/10.3857\/roj.2023.01032.","journal-title":"Radiat Oncol J"},{"key":"4259_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bjs.1800691019","volume":"69","author":"RJ Heald","year":"1982","unstructured":"Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery\u2014the clue to pelvic recurrence? Br J Surg. 1982;69:613\u20136. https:\/\/doi.org\/10.1002\/bjs.1800691019.","journal-title":"Br J Surg"},{"key":"4259_CR8","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1200\/JCO.2004.09.059","volume":"22","author":"S Gill","year":"2004","unstructured":"Gill S, Loprinzi CL, Sargent DJ, Thom\u00e9 SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004;22:1797\u2013806. https:\/\/doi.org\/10.1200\/JCO.2004.09.059.","journal-title":"J Clin Oncol"},{"key":"4259_CR9","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0039-6109(02)00050-6","volume":"82","author":"WE Longo","year":"2002","unstructured":"Longo WE, Johnson FE. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am. 2002;82:1091\u2013108. https:\/\/doi.org\/10.1016\/S0039-6109(02)00050-6.","journal-title":"Surg Clin North Am"},{"key":"4259_CR10","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.clcc.2019.01.003","volume":"18","author":"SY Guraya","year":"2019","unstructured":"Guraya SY. Pattern, stage, and time of recurrent colorectal cancer after curative surgery. Clin Colorectal Cancer. 2019;18:e223\u20138. https:\/\/doi.org\/10.1016\/j.clcc.2019.01.003.","journal-title":"Clin Colorectal Cancer"},{"key":"4259_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00384-013-1675-z","volume":"28","author":"JW Huh","year":"2013","unstructured":"Huh JW, Kim CH, Lim SW, Kim HR, Kim YJ. Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival? Int J Colorectal Dis. 2013;28:1143\u20139. https:\/\/doi.org\/10.1007\/s00384-013-1675-z.","journal-title":"Int J Colorectal Dis"},{"key":"4259_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00268-018-4774-8","volume":"43","author":"CH Kim","year":"2019","unstructured":"Kim CH, Yeom SS, Lee SY, Kim HR, Kim YJ, Lee KH, et al. Prognostic impact of perineural invasion in rectal cancer after neoadjuvant chemoradiotherapy. World J Surg. 2019;43:260\u201372. https:\/\/doi.org\/10.1007\/s00268-018-4774-8.","journal-title":"World J Surg"},{"key":"4259_CR13","first-page":"1229","volume":"32","author":"HP Wang Jun","year":"2022","unstructured":"Wang Jun HP. Prognostic value of perineural invasion in yp\u2160-\u2161 rectal cancer patients who received neoadjuvant radiotherapy. China Oncol. 2022;32:1229\u201334.","journal-title":"China Oncol"},{"key":"4259_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10936-w","volume":"23","author":"L Qin","year":"2023","unstructured":"Qin L, Heng Y, Deng S, Gu J, Mao F, Xue Y, et al. Perineural invasion affects prognosis of patients undergoing colorectal cancer surgery: a propensity score matching analysis. BMC Cancer. 2023;23:452. https:\/\/doi.org\/10.1186\/s12885-023-10936-w.","journal-title":"BMC Cancer"},{"key":"4259_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-023-00857-y","volume":"47","author":"H Wang","year":"2024","unstructured":"Wang H, Huo R, He K, Cheng L, Zhang S, Yu M, et al. Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance. Cell Oncol (Dordr). 2024;47:1\u201317. https:\/\/doi.org\/10.1007\/s13402-023-00857-y.","journal-title":"Cell Oncol (Dordr)"},{"key":"4259_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217483","volume":"612","author":"J Zhao","year":"2025","unstructured":"Zhao J, Cheng L, Yang J, Xu F, Qi W, Liao K, et al. Tumor-nerve interactions in cancer regulation and progression. Cancer Lett. 2025;612:217483. https:\/\/doi.org\/10.1016\/j.canlet.2025.217483.","journal-title":"Cancer Lett"},{"key":"4259_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113691","volume":"155","author":"Q Liu","year":"2022","unstructured":"Liu Q, Ma Z, Cao Q, Zhao H, Guo Y, Liu T, et al. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691. https:\/\/doi.org\/10.1016\/j.biopha.2022.113691.","journal-title":"Biomed Pharmacother"},{"key":"4259_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3393\/jksc.2008.24.4.265","volume":"24","author":"SH Jung","year":"2008","unstructured":"Jung SH, Kim HC, Kim AY, Choi PW, Park IJ, Yu CS, et al. Colorectal cancer presenting as an early recurrence within 1 year after a curative resection. J Korean Soc Coloproctol. 2008;24:265\u201372. https:\/\/doi.org\/10.3393\/jksc.2008.24.4.265.","journal-title":"J Korean Soc Coloproctol"},{"key":"4259_CR19","doi-asserted-by":"publisher","unstructured":"China Z, Drmota J, Chowdhury A. 1208 Surveillance strategy following curative resection of colorectal cancer\u2014what and when? BJS. 2024;111:Supplement_6. https:\/\/doi.org\/10.1093\/bjs\/znae163.384.","DOI":"10.1093\/bjs\/znae163.384"},{"key":"4259_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00595-021-02336-z","volume":"52","author":"H Furuke","year":"2021","unstructured":"Furuke H, Arita T, Kuriu Y, Shimizu H, Kiuchi J, Yamamoto Y, et al. The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resection. Surg Today. 2021;52:239\u201350. https:\/\/doi.org\/10.1007\/s00595-021-02336-z.","journal-title":"Surg Today"},{"key":"4259_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4174\/astr.2014.86.3.143","volume":"86","author":"JP Ryuk","year":"2014","unstructured":"Ryuk JP, Choi GS, Park JS, Kim HJ, Park SY, Yoon GS, et al. Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann Surg Treat Res. 2014;86:143\u201351. https:\/\/doi.org\/10.4174\/astr.2014.86.3.143.","journal-title":"Ann Surg Treat Res"},{"key":"4259_CR22","first-page":"675","volume":"34","author":"Q-Z Liu","year":"2019","unstructured":"Liu Q-Z, et al. Correlation of early and late recurrence with clinical and pathological factors in postoperative colorectal cancer patients. Chin J Gen Surg. 2019;34:675\u20138.","journal-title":"Chin J Gen Surg"},{"key":"4259_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081883","volume":"13","author":"YT Lan","year":"2021","unstructured":"Lan YT, Chang SC, Lin PC, Lin CC, Lin HH, Huang SC, et al. Clinicopathological and molecular features of patients with early and late recurrence after curative surgery for colorectal cancer. Cancers (Basel). 2021;13:1883. https:\/\/doi.org\/10.3390\/cancers13081883.","journal-title":"Cancers (Basel)"},{"key":"4259_CR24","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.ejso.2020.07.019","volume":"46","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Wang X, Huang Y, Lu X, Huang Z, Chi P. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Eur J Surg Oncol. 2020;46:2057\u201363. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.019.","journal-title":"Eur J Surg Oncol"},{"key":"4259_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12029-017-9984-z","volume":"49","author":"WJ Tan","year":"2018","unstructured":"Tan WJ, Tan HJ, Dorajoo SR, Foo FJ, Tang CL, Chew MH. Rectal cancer surveillance-recurrence patterns and survival outcomes from a cohort followed up beyond 10 years. J Gastrointest Cancer. 2018;49:422\u20138. https:\/\/doi.org\/10.1007\/s12029-017-9984-z.","journal-title":"J Gastrointest Cancer"},{"key":"4259_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1034838","volume":"12","author":"H-X Yang","year":"2022","unstructured":"Yang H-X, Chen L, Wu X, Zhang C, Yao Z, Xing J, et al. Patterns and predictors of recurrence after laparoscopic resection of rectal cancer. Front Oncol. 2022;12:1034838. https:\/\/doi.org\/10.3389\/fonc.2022.1034838.","journal-title":"Front Oncol"},{"key":"4259_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03136-0","volume":"21","author":"R Okamura","year":"2023","unstructured":"Okamura R, Itatani Y, Fujita Y, Hoshino N, Okumura S, Nishiyama K, et al. Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern? World J Surg Oncol. 2023;21:247. https:\/\/doi.org\/10.1186\/s12957-023-03136-0.","journal-title":"World J Surg Oncol"},{"key":"4259_CR28","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731\u201340. https:\/\/doi.org\/10.1056\/NEJMoa040694.","journal-title":"N Engl J Med"},{"key":"4259_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","volume":"35","author":"T Conroy","year":"2024","unstructured":"Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35:873\u201381. https:\/\/doi.org\/10.1016\/j.annonc.2024.06.019.","journal-title":"Ann Oncol"},{"key":"4259_CR30","doi-asserted-by":"publisher","first-page":"e1555","DOI":"10.1002\/onco.13824","volume":"26","author":"S Liu","year":"2021","unstructured":"Liu S, Jiang T, Xiao L, Yang S, Liu Q, Gao Y, et al. Total neoadjuvant therapy (TNT) versus Standard neoadjuvant chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. Oncologist. 2021;26:e1555\u201366. https:\/\/doi.org\/10.1002\/onco.13824.","journal-title":"Oncologist"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04259-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04259-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04259-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:15:55Z","timestamp":1774613755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04259-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4259"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04259-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Gil Medical Center approved this retrospective observational study and waived the requirement for patient informed consent (IRB number GAIRB2023-332).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}